Literature DB >> 2414412

Neuropeptides in neurological tumours.

J M Allen, N R Hoyle, J C Yeats, M A Ghatei, D G Thomas, S R Bloom.   

Abstract

Concentrations of seven neuropeptides have been determined in 69 human neurological tumours. The majority of tumours were intrinsic to the central nervous system, being astrocytomas. In general, within the the better differentiated tumours (Grade I/II astrocytomas) higher concentrations of five neuropeptides (neuropeptide Y, somatostatin, substance P, vasoactive intestinal peptide and cholecystokinin) were measured in comparison to the poorly differentiated tumours. Of the metastatic tumours, five were derived from oat cell carcinoma of the bronchus. Very high concentrations of bombesin were identified in these metastases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414412     DOI: 10.1007/bf00165179

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  Induction of some features of glial differentiation in primary cultures of human gliomas by treatment with dibutyrl cyclic AMP.

Authors:  L W Haynes; R O Weller
Journal:  Br J Exp Pathol       Date:  1978-06

2.  The origin, distribution and synaptic relationships of substance P axons in rat spinal cord.

Authors:  R P Barber; J E Vaughn; J R Slemmon; P M Salvaterra; E Roberts; S E Leeman
Journal:  J Comp Neurol       Date:  1979-03-15       Impact factor: 3.215

3.  Radioimmunoassay of substance P and its stability in tissue.

Authors:  G P McGregor; S R Bloom
Journal:  Life Sci       Date:  1983-02-07       Impact factor: 5.037

4.  Magnocellular neuropeptidergic terminals in neurohypophysis: rapid glial release of enclosed axons during parturition.

Authors:  C D Tweedle; G I Hatton
Journal:  Brain Res Bull       Date:  1982-02       Impact factor: 4.077

5.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

6.  A radioimmunoassay for neurotensin in human plasma.

Authors:  A M Blackburn; S R Bloom
Journal:  J Endocrinol       Date:  1979-11       Impact factor: 4.286

7.  Determination of glial fibrillary acidic protein (GFAP) in human brain tumors.

Authors:  C M Jacque; C Vinner; M Kujas; M Raoul; J Racadot; N A Baumann
Journal:  J Neurol Sci       Date:  1978-01       Impact factor: 3.181

8.  Human lung small-cell carcinoma contains bombesin.

Authors:  M D Erisman; R I Linnoila; O Hernandez; R P DiAugustine; L H Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

9.  Glial fibrillary acidic protein in human gliomas.

Authors:  J D van der Meulen; H J Houthoff; E J Ebels
Journal:  Neuropathol Appl Neurobiol       Date:  1978 May-Jun       Impact factor: 8.090

10.  Antigens in human glioblastomas and meningiomas: Search for tumour and onco-foetal antigens. Estimation of S-100 and GFA protein.

Authors:  L Dittmann; N H Axelsen; B Norgaard-Pedersen; E Bock
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

View more
  5 in total

1.  Elevated blood markers 1 year before manifestation of malignant glioma.

Authors:  Wolfgang Gartner; Aysegül Ilhan; Dashurie Neziri; Wolfgang Base; Michael Weissel; Adelheid Wöhrer; Harald Heinzl; Thomas Waldhör; Ludwig Wagner; Matthias Preusser
Journal:  Neuro Oncol       Date:  2010-04-08       Impact factor: 12.300

2.  Neuropeptide Y, somatostatin, and cholecystokinin neurone preservation in anaplastic astrocytomas.

Authors:  S Przedborski; S Goldman; S N Schiffmann; G Vierendeels; M Depierreux; M Levivier; J Hildebrand; J J Vanderhaeghen
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.

Authors:  C Palma; M Bigioni; C Irrissuto; F Nardelli; C A Maggi; S Manzini
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

Review 4.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

5.  Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.

Authors:  C Palma; F Nardelli; S Manzini; C A Maggi
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.